WuXi Healthcare Ventures Joins $115M Series E Round In 23andMe

Login to View

Mountain View, California-based DNA testing firm 23andMe, Inc. has completed US$115 million series E financing round led by Fidelity Management & Research Company, with participation from new investors including WuXi Healthcare Ventures.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in